Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$234K Sell
1,341
-81
-6% -$16.6K 0.01% 684
2025
Q4
$365K Hold
1,422
0.02% 625
2025
Q3
$371K Sell
1,422
-149
-9% -$39.2K 0.02% 633
2025
Q2
$386K Buy
1,571
+124
+9% +$30.9K 0.02% 577
2025
Q1
$384K Sell
1,447
-50
-3% -$13.5K 0.02% 543
2024
Q4
$381K Sell
1,497
-202
-12% -$54.2K 0.02% 531
2024
Q3
$540K Sell
1,699
-1,325
-44% -$472K 0.24% 117
2024
Q2
$1.13M Sell
3,024
-598
-17% -$202K 0.53% 39
2024
Q1
$1.26M Buy
3,622
+209
+6% +$79.2K 0.65% 33
2023
Q4
$1.57M Buy
3,413
+595
+21% +$293K 0.84% 19
2023
Q3
$1.37M Buy
2,818
+300
+12% +$141K 0.76% 18
2023
Q2
$1.13M Sell
2,518
-15
-0.6% -$7.55K 0.64% 27
2023
Q1
$1.23M Buy
2,533
+40
+2% +$19.8K 0.73% 20
2022
Q4
$1.28M Buy
+2,493
New +$1.31M 0.19% 85
2022
Q2
Sell
-2,051
Closed -$894K 622
2022
Q1
$894K Buy
2,051
+176
+9% +$73.6K 0.08% 205
2021
Q4
$871K Hold
1,875
0.1% 196
2021
Q3
$731K Buy
1,875
+40
+2% +$17K 0.11% 198
2021
Q2
$813K Hold
1,835
0.12% 181
2021
Q1
$770K Buy
+1,835
New +$733K 0.14% 155
2020
Q4
Sell
-494
Closed -$205K 370
2020
Q3
$205K Buy
+494
New +$199K 0.07% 309

Other funds holding HUM

StoneX Group's HUM Position: Q1 2026 in Review

StoneX Group reduced its Humana (HUM) stake by 5.7% in Q1 2026, selling an estimated $16.6K and leaving 1,341 shares worth $234K. The position accounts for 0.01% of the portfolio, ranked #684.

StoneX Group first reported a position in HUM in Q3 2020 and has held it in 20 quarters since. The position peaked at $1.57M in Q4 2023. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • StoneX Group held 1,341 shares of Humana worth $234K as of Q1 2026.
  • StoneX Group sold 81 Humana shares in Q1 2026, an estimated $16.6K.
  • Humana made up 0.01% of StoneX Group's portfolio in Q1 2026, its #684 holding.
  • StoneX Group first reported a position in Humana in Q3 2020 and has held it in 20 quarters since.
  • StoneX Group's Humana position peaked at $1.57M in Q4 2023.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.